Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Dr. Claire de la Calle

๐Ÿ‘ค Speaker
340 total appearances

Appearances Over Time

Podcast Appearances

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

So if you don't see cribriform, it doesn't mean it's not actually there.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

But the specificity does seem to be quite high for both large curb reform and introductal carcinoma.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

So when I see it, I really believe it.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And we do have several studies that have shown that patients with large curb reform type pattern 4 and introductal carcinoma definitely have much worse oncologic outcomes.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

So in my practice, it is an exclusion criteria for active surveillance.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Now, the problem is that there's a lot of discrepancy in how curb reform is reported.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Some pathologists don't report it.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Sometimes small cribriform is reported versus large.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And small cribriform, what is the significance of this on biopsy?

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

How accurate is it?

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Is it as specific as large cribriform?

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Personally, I don't think so, although I think we need to do more research on these active surveillance with small cribriform.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

So I do have some patients with small cribriform that I monitor.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

closely that I do monitor.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

But large cribriform and intraductal, I do consider exclusion criteria for active surveillance.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And I do want to mention one more pathologic feature, and that's perineural invasion.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Similar to cribriform, there's a great variability in how it's reported.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Some pathologists don't report it.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

There are different definitions of what perineural invasion is.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And